WASHINGTON, D.C.— On Tuesday, January 3rd, the Food and Drug Administration (FDA) updated labeling for mifepristone (generic for Mifeprex) that would allow pharmacies (both online and brick and mortar) to dispense the drug.
In issuing the new regulations, the FDA formalized a decision made in 2021 to permanently drop the in-person requirement for the distribution of the abortion pill.
“The abortion industry wants to put at risk perfectly healthy mothers who are pregnant with perfectly healthy babies,” said Carol Tobias, president of National Right to Life. “None of these changes make this process safer for the woman. What these changes do is make the process easier and cheaper for the abortion industry.”
(read more)
In issuing the new regulations, the FDA formalized a decision made in 2021 to permanently drop the in-person requirement for the distribution of the abortion pill.
“The abortion industry wants to put at risk perfectly healthy mothers who are pregnant with perfectly healthy babies,” said Carol Tobias, president of National Right to Life. “None of these changes make this process safer for the woman. What these changes do is make the process easier and cheaper for the abortion industry.”
(read more)
RSS Feed
